| EPA082 | Machine learning prediction and phyloanatomic modeling of viral neuroadaptive signatures in the macaque model of human immunodeficiency virus-mediated neuropathology | E-poster | Neuropathogenesis |
| PESUA24 | Chronic CNS inflammation in ART-suppressed SIV-infected rhesus macaques is associated with immune activation and viral persistence in the gut | Poster exhibition | Neuropathogenesis |
| EPB068 | A 2-year longitudinal examination of dosage of speed of processing training on Useful Field of View performance in adults 40+ with HIV-associated neurocognitive disorder: findings from the ThinkFast Study | E-poster | Neurologic disorders (e.g. CNS malignancies) |
| PESUB14 | Low frequency of activated T cells in people living with HIV, aviremic under treatment, and presenting neurocognitive disorders | Poster exhibition | Neurologic disorders (e.g. CNS malignancies) |
| EPC002 | Assessment of cardiovascular health using the "Life's Simple 7" among the Canadian HIV and Aging Cohort study participants: a cross-sectional observational study | E-poster | Natural history, morbidity patterns and survival |
| EPC003 | Survival and determinants of mortality among HIV infected persons in rural Malawi: a historical cohort study of before test and treat strategy | E-poster | Natural history, morbidity patterns and survival |
| EPC004 | Geographic variation in 5-year mortality following HIV diagnosis: implications for clinical interventions | E-poster | Natural history, morbidity patterns and survival |
| EPC005 | Most common causes of death among persons living with HIV ' Zambia, February 2020-January 2022 | E-poster | Natural history, morbidity patterns and survival |
| EPC006 | Causes of death for persons with HIV in an integrated healthcare system in Northern California, 2013-2017 | E-poster | Natural history, morbidity patterns and survival |
| EPE204 | HIV trust fund of Nigeria: a private sector driven sustainable domestic financing mechanism and paradigm shift in local funding | E-poster | National financing analyses and financing mechanisms for HIV, hepatitis and STI programmes and services |